Press Releases
Crestone, Inc. joins the Antimicrobials Working Group to Combat Drug Resistant Infections
June 8, 2021. The Antimicrobials Working Group (AWG) announced today the addition of...
Read More
First Patient Enrolled in Phase 2 Clinical Trial + QIDP & Fast Track Designations
Crestone, Inc. Enrolls First Patient in Phase 2 Clinical Trial for Novel Antibiotic CRS3123 to...
Read More
NIH Funding Secured for Development Through Phase 1 of Novel Antibiotic Candidate CRS0540
Crestone, Inc. Secures NIH Funding for Development Through Phase 1 of Novel Antibiotic Candidate...
Read More
Grant Received from State of Colorado Advanced Industries Accelerator program
May 29, 2020. Crestone, Inc. receives $250,000 Grant from State of Colorado Advanced...
Read More
NIH Funding Secured for Preclinical Development of Novel Antibiotic CRS3123
Crestone, Inc. Secures NIH Funding for Preclinical Development of Novel Antibiotic CRS3123 to...
Read More
CFF Funding Secured for Preclinical Development of Novel Antibiotic to Treat NTM Infections
Crestone, Inc. (Boulder) Secures CFF Funding for Preclinical Development of Novel Antibiotic to...
Read More
NIH Funding Secured for Phase 2 Clinical Trial of Novel Antibiotic Candidate, CRS3123
Crestone, Inc. Secures NIH Funding for Phase 2 Clinical Trial of Novel Antibiotic Candidate,...
Read More
Research Agreement with Colorado University at Boulder
Crestone enters a Research Agreement with Colorado University at Boulder to develop efflux pump...
Read More
Crestone Awarded a Phase II SBIR Grant: “Optimization and Lead Selection of Novel Antimycobacterial Agents”
Award Information InfoData Agency:Department of Health and Human Services Branch:National...
Read More
Other News
Presentations at the 2022 ASM Microbe
Oral Session: In vivo Pharmacodynamic Evaluation of CRS0540 in the Murine Thigh and Lung Infection...
Become a Part of Our Projects
Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investor, a team member, or a participant in our ongoing clinical studies.
Inquiries
Have a question or comment? Follow the link below to contact us about general inquiries.
Careers
Find work in a team-oriented environment at one of the leading Colorado pharma companies.
Clinical Studies
Learn how you can become part of our ongoing clinical study to fight deadly GI tract infections.